These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23648017)

  • 1. Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis.
    Islam M; Sharma S; Kumar B; Teknos TN
    Oral Oncol; 2013 Aug; 49(8):778-86. PubMed ID: 23648017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells.
    Collisson EA; Kleer C; Wu M; De A; Gambhir SS; Merajver SD; Kolodney MS
    Mol Cancer Ther; 2003 Oct; 2(10):941-8. PubMed ID: 14578459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk1/2 signaling pathway in head and neck squamous cell carcinoma.
    Islam M; Datta J; Lang JC; Teknos TN
    Oral Oncol; 2014 May; 50(5):448-56. PubMed ID: 24565984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion.
    Fromigué O; Hamidouche Z; Marie PJ
    J Biol Chem; 2008 Nov; 283(45):30549-56. PubMed ID: 18757369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RhoC regulates cancer stem cells in head and neck squamous cell carcinoma by overexpressing IL-6 and phosphorylation of STAT3.
    Islam M; Sharma S; Teknos TN
    PLoS One; 2014; 9(2):e88527. PubMed ID: 24533098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma.
    Pan Q; Bao LW; Teknos TN; Merajver SD
    Cancer Res; 2006 Oct; 66(19):9379-84. PubMed ID: 17018591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RhoC expression and head and neck cancer metastasis.
    Islam M; Lin G; Brenner JC; Pan Q; Merajver SD; Hou Y; Kumar P; Teknos TN
    Mol Cancer Res; 2009 Nov; 7(11):1771-80. PubMed ID: 19861405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis.
    Shachaf CM; Perez OD; Youssef S; Fan AC; Elchuri S; Goldstein MJ; Shirer AE; Sharpe O; Chen J; Mitchell DJ; Chang M; Nolan GP; Steinman L; Felsher DW
    Blood; 2007 Oct; 110(7):2674-84. PubMed ID: 17622571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
    Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
    Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux.
    Argmann CA; Edwards JY; Sawyez CG; O'Neil CH; Hegele RA; Pickering JG; Huff MW
    J Biol Chem; 2005 Jun; 280(23):22212-21. PubMed ID: 15817453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase.
    Cao Z; Fan-Minogue H; Bellovin DI; Yevtodiyenko A; Arzeno J; Yang Q; Gambhir SS; Felsher DW
    Cancer Res; 2011 Mar; 71(6):2286-97. PubMed ID: 21262914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes.
    Takaguri A; Satoh K; Itagaki M; Tokumitsu Y; Ichihara K
    J Pharmacol Sci; 2008 May; 107(1):80-9. PubMed ID: 18469500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin.
    Li M; Liu Y; Dutt P; Fanburg BL; Toksoz D
    Am J Physiol Lung Cell Mol Physiol; 2007 Aug; 293(2):L463-71. PubMed ID: 17545489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Rho and Rac geranylgeranylation by atorvastatin is critical for preservation of endothelial junction integrity.
    Xiao H; Qin X; Ping D; Zuo K
    PLoS One; 2013; 8(3):e59233. PubMed ID: 23555637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice.
    Liao J; Chung YT; Yang AL; Zhang M; Li H; Zhang W; Yan L; Yang GY
    Mol Carcinog; 2013 Sep; 52(9):739-50. PubMed ID: 22549877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
    Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
    Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
    Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
    Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity.
    Finlay GA; Malhowski AJ; Liu Y; Fanburg BL; Kwiatkowski DJ; Toksoz D
    Cancer Res; 2007 Oct; 67(20):9878-86. PubMed ID: 17942919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors.
    Rashid M; Tawara S; Fukumoto Y; Seto M; Yano K; Shimokawa H
    Circ J; 2009 Feb; 73(2):361-70. PubMed ID: 19060417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells.
    Ghalali A; Wiklund F; Zheng H; Stenius U; Högberg J
    Carcinogenesis; 2014 Jul; 35(7):1547-55. PubMed ID: 24451147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.